Reduction of Blood Glucose Measurements to Calibrate Subcutaneous Glucose Sensors: A Bayesian Multiday Framework
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: In most continuous glucose monitoring (CGM) devices used for diabetes management, the electrical signal measured by the sensor is transformed to glucose concentration by a calibration function whose parameters are estimated using self-monitoring of blood glucose (SMBG) samples. The calibration function is usually a linear model approximating the nonlinear relationship between electrical signal and glucose concentration in certain time intervals. Thus, CGM devices require frequent calibrations, usually twice a day. The aim here is to develop a new method able to reduce the frequency of calibrations. METHODS: The algorithm is based on a multiple-day model of sensor time-variability with second-order statistical priors on its unknown parameters. In an online setting, these parameters are numerically determined by the Bayesian estimation exploiting SMBG sparsely collected by the patient. The method is assessed retrospectively on 108 CGM signals acquired for 7 days by the Dexcom G4 Platinum sensor, testing progressively less-calibration scenarios. RESULTS: Despite the reduction of calibration frequency (on average from 2/day to 0.25/day), the method shows a statistically significant accuracy improvement compared to manufacturer calibration, e.g., mean absolute relative difference when compared to a laboratory reference decreases from 12.83% to 11.62% (p-value of 0.006). CONCLUSION: The methodology maintains (sometimes improves) CGM sensor accuracy compared to that of the original manufacturer, while reducing the frequency of calibrations. SIGNIFICANCE: Reducing the need of calibrations facilitates the adoption of CGM technology both in terms of ease of use and cost, an obvious prerequisite for its use as replacement of traditional SMBG devices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Glucose Biosensors: An Overview of Use in Clinical Practice
Yoo, E.-H., & Lee, S.-Y. (2010) · Sensors · doi:10.3390/s100504558 · Cited by 1,137 · cited 1×
“The use of continuous glucose monitoring (CGM) sensors [2] can render diabetes management easier for the patient and, at the same time, therapeutically more efficient.”
BackgroundThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 1×
“In order to facilitate adoption of CGM technologies, reducing the number of calibrations is thus among the priorities of manufacturers, as witnessed by the recent launch on the market of the FreeStyle Libre (Abbott Diabetes Care, Alameda, CA), a factory-calibrated flash glucose monitor able to display, for up to 14 da…”
BackgroundContinuous glucose monitoring sensors: past, present and future algorithmic challenges
Facchinetti, A. (2016) · Sensors · doi:10.3390/s16122093 · Cited by 176 · cited 1×
“used to make daily diabetes treatment decisions without finger pricking [16], [17] (see http://www.”
MethodSelf-citationClinical accuracy of a continuous glucose monitoring system with an advanced algorithm
Bailey, T. S., Chang, A., & Christiansen, M. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814559746 · Cited by 168 · cited 1×
“system, as in [26], and not to the newer system with updated software [38] currently on the market.”
BackgroundRebrin, K., Sheppard, N. F., & Steil, G. M. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400507 · Cited by 152
Regulation Catches Up to Reality: Nonadjunctive Use of Continuous Glucose Monitoring Data
Edelman, S. V. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816667749 · Cited by 51 · cited 1×
“used to make daily diabetes treatment decisions without finger pricking [16], [17] (see http://www.”
Method
Cited by
Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment
Cappon, G., Acciaroli, G., Vettoretti, M., Facchinetti, A., & Sparacino, G. (2017) · Electronics · doi:10.3390/electronics6030065 · Cited by 237
Self-citationContinuous glucose monitoring: Current use in diabetes management and possible future applications
Vettoretti, M., Cappon, G., Acciaroli, G., Facchinetti, A., & Sparacino, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818774078 · Cited by 96
“However, the CGM usability is rapidly improving because of increases in sensor accuracy,(25-32) extension of the sensor wear time, and decreases in calibration requirements.(33-37) Moreover, some CGM devices received regulatory approval for nonadjunctive use; that is, the patient can make treatment decisions without u…”
BackgroundCappon, G., Vettoretti, M., Marturano, F., Facchinetti, A., & Sparacino, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818759558 · Cited by 62
Self-citationLimits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials
Schrangl, P., Reiterer, F., Heinemann, L., Freckmann, G., & Del Re, L. (2018) · Biosensors · doi:10.3390/bios8020050 · Cited by 46
Metadata
- Authors
- Acciaroli, G., Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C.
- Venue
- IEEE Transactions on Biomedical Engineering
- Published
- 2018-03
- Volume
- 65
- Issue
- 3
- Pages
- 587-595
- ISSN
- 0018-9294 (ISSN-L)
- 1558-2531
- OpenAlex
- W2619079930
- Cited by
- 36
- References
- 7
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.